HCG to invest up to Rs 7 Cr in Kenya step-down unit, back its loan
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HCG will buy up to 10% more shares in Cancer Care Kenya (CCK), its step-down subsidiary, for up to Rs 7 Cr in cash. It will also issue a Standby Letter of Credit to back a USD 1.8 million (about Rs 16 Cr) term loan CCK is raising for expansion. HCG liability could reach 105% of the loan. CCK runs a cancer hospital in Nairobi with FY25 revenue of Rs 42.53 Cr and PAT of Rs 10.83 Cr. Deal to close by March 2026.
Modest capital commitment into a fast-growing Kenya unit; SBLC adds contingent liability risk if subsidiary's expansion underperforms.